Snyder Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-241,053
| Closed | -$16.9M | – | 74 |
|
|
2022
Q1 | $16.9M | Sell |
241,053
-5,851
| -2% | -$411K | 0.43% | 68 |
|
|
2021
Q4 | $23.8M | Buy |
246,904
+43,418
| +21% | +$4.18M | 0.57% | 63 |
|
|
2021
Q3 | $17.7M | Sell |
203,486
-1,922
| -0.9% | -$167K | 0.47% | 68 |
|
|
2021
Q2 | $16.8M | Buy |
205,408
+76,366
| +59% | +$6.25M | 0.47% | 63 |
|
|
2021
Q1 | $12.3M | Sell |
129,042
-172,813
| -57% | -$16.4M | 0.35% | 68 |
|
|
2020
Q4 | $18.7M | Buy |
301,855
+24,687
| +9% | +$1.53M | 0.61% | 58 |
|
|
2020
Q3 | $16.5M | Sell |
277,168
-363
| -0.1% | -$21.6K | 0.71% | 48 |
|
|
2020
Q2 | $19.4M | Buy |
277,531
+2,913
| +1% | +$203K | 0.88% | 38 |
|
|
2020
Q1 | $12.5M | Buy |
+274,618
| New | +$12.5M | 0.71% | 47 |
|